XML 27 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Discontinued Operations
9 Months Ended
Sep. 30, 2025
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations

3. DISCONTINUED OPERATIONS

Mural Oncology Separation

In connection with the Separation, the Company and Mural entered into, among other agreements: a separation agreement; a tax matters agreement; and an employee matters agreement, which are described in Note 3, Discontinued Operations in the “Notes to Consolidated Financial Statements” accompanying the Annual Report.

 

Discontinued Operations

The Company determined that the Separation met the criteria for classification of its former oncology business as discontinued operations in accordance with Topic 205. During the three and nine months ended September 30, 2025, the Company recorded no losses from discontinued operations. The following summarizes the losses from discontinued operations for the three and nine months ended September 30, 2024:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

(In thousands)

 

September 30, 2024

 

 

September 30, 2024

 

Operating expenses from discontinued operations

 

 

 

 

 

 

Cost of goods manufactured

 

$

 

 

$

 

Research and development

 

 

481

 

 

 

6,910

 

Selling, general and administrative

 

 

 

 

 

 

Total operating expenses from discontinued operations

 

 

481

 

 

 

6,910

 

Operating loss from discontinued operations

 

 

(481

)

 

 

(6,910

)

Income tax benefit from discontinued operations

 

 

(67

)

 

 

(1,076

)

Net loss and comprehensive loss from discontinued operations

 

$

(414

)

 

$

(5,834

)